Showing results (371-380 of 405) with videos related to

Sort By:
Pageof 41
The Oncologist|April 25, 2014
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarateAmir T Fathi, Hossein Sadrzadeh, Amy H Comander, et al.
Chembiochem : a European Journal of Chemical Biology|July 3, 2025
Covalent Stabilization of Collagen Mimetic Triple Helices and Assemblies by Dopa CrosslinkingCarson Cole, Brett H Pogostin, Vardan H Vardanyan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered miceZhenyue Hao, Rob A Cairns, Satoshi Inoue, et al.
Nature Chemistry|July 15, 2024
Heterotrimeric collagen helix with high specificity of assembly results in a rapid rate of foldingCarson C Cole, Douglas R Walker, Sarah A H Hulgan, et al.
Clinical Cardiology|May 11, 2012
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 TrialDavid E Kandzari, Deepak L Bhatt, Paul A Sobotka, et al.
Chemical Science|April 15, 2026
Molecular jackhammers induce intracellular calcium release and skeletal muscle contraction by vibronic-driven actionYuchen Rui, Bowen Li, Vardan Vardanyan, et al.
Nature Genetics|November 8, 2011
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2M Fernanda Amary, Stephen Damato, Dina Halai, et al.
Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 31, 2006
Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small moleculesFredrick Van Goor, Kimberly S Straley, Dong Cao, et al.
The Journal of Infectious Diseases|July 14, 2026
Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem HelixFrancesco Borriello, Gavin C K W Koh, Iñaki F Troconiz, et al.
Pageof 41